1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > United States Drug Eluting Stents (DES) Industry 2016 Market Research Report

The United States Drug Eluting Stents (DES) Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Drug Eluting Stents (DES) industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Drug Eluting Stents (DES) market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Drug Eluting Stents (DES) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 148 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Table Of Contents

United States Drug Eluting Stents (DES) Industry 2016 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Drug Eluting Stents (DES)
1.1.1 Definition of Drug Eluting Stents (DES)
1.1.2 Specifications of Drug Eluting Stents (DES)
1.2 Classification of Drug Eluting Stents (DES)
1.3 Applications of Drug Eluting Stents (DES)
1.4 Industry Chain Structure of Drug Eluting Stents (DES)
1.5 Industry Overview of Drug Eluting Stents (DES)
1.6 Industry Policy Analysis of Drug Eluting Stents (DES)
1.7 Industry News Analysis of Drug Eluting Stents (DES)

2 Manufacturing Cost Structure Analysis of Drug Eluting Stents (DES)
2.1 Bill of Materials (BOM) of Drug Eluting Stents (DES)
2.2 BOM Price Analysis of Drug Eluting Stents (DES)
2.3 Labor Cost Analysis of Drug Eluting Stents (DES)
2.4 Depreciation Cost Analysis of Drug Eluting Stents (DES)
2.5 Manufacturing Cost Structure Analysis of Drug Eluting Stents (DES)
2.6 Manufacturing Process Analysis of Drug Eluting Stents (DES)
2.7 United States Price, Cost and Gross of Drug Eluting Stents (DES) 2011-2016

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Drug Eluting Stents (DES) Manufacturers in 2015
3.3 RandD Status and Technology Source of United States Drug Eluting Stents (DES) Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Drug Eluting Stents (DES) Key Manufacturers in 2015

4 Production Analysis of Drug Eluting Stents (DES) by Regions, Type, and Applications
4.1 United States Production of Drug Eluting Stents (DES) by Regions 2011-2016
4.2 United States Production of Drug Eluting Stents (DES) by Type 2011-2016
4.3 United States Sales of Drug Eluting Stents (DES) by Applications 2011-2016
4.4 Price Analysis of United States Drug Eluting Stents (DES) Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Drug Eluting Stents (DES) 2011-2016

5 Consumption Volume and Consumption Value Analysis of Drug Eluting Stents (DES) by Regions
5.1 United States Consumption Volume of Drug Eluting Stents (DES) by Regions 2011-2016
5.2 United States Consumption Value of Drug Eluting Stents (DES) by Regions 2011-2016
5.3 United States Consumption Price Analysis of Drug Eluting Stents (DES) by Regions 2011-2016

6 Analysis of Drug Eluting Stents (DES) Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Drug Eluting Stents (DES) 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Drug Eluting Stents (DES) 2014-2015
6.3 Sales Overview of Drug Eluting Stents (DES) 2011-2016
6.4 Supply, Consumption and Gap of Drug Eluting Stents (DES) 2011-2016
6.5 Import, Export and Consumption of Drug Eluting Stents (DES) 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Drug Eluting Stents (DES) 2011-2016

7 Analysis of Drug Eluting Stents (DES) Industry Key Manufacturers
7.1 Abbott
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information

7.2 Medtronic
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information

7.3 Terumo
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information

7.4 Biosensors International
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information

7.5 AlviMedica
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information

7.6 Zorion Medical Company
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information

7.7 BioSurfaces
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information

7.8 Biotronik
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information

7.9 Boston Scientific
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information

7.10 ICON Medical
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information

7.11 Xenogenics Corporation Company
7.11.1 Company Profile
7.11.2 Product Picture and Specifications
7.11.2.1 Type I
7.11.2.2 Type II
7.11.2.3 Type III
7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
7.11.4 Contact Information

7.12 VasoTech Inc. Company
7.12.1 Company Profile
7.12.2 Product Picture and Specifications
7.12.2.1 Type I
7.12.2.2 Type II
7.12.2.3 Type III
7.12.3 Capacity, Production, Price, Cost, Gross and Revenue
7.12.4 Contact Information

7.13 University of Strathclyde Company
7.13.1 Company Profile
7.13.2 Product Picture and Specifications
7.13.2.1 Type I
7.13.2.2 Type II
7.13.2.3 Type III
7.13.3 Capacity, Production, Price, Cost, Gross and Revenue
7.13.4 Contact Information

7.14 Tryton Medical, Inc. Company
7.14.1 Company Profile
7.14.2 Product Picture and Specifications
7.14.2.1 Type I
7.14.2.2 Type II
7.14.2.3 Type III
7.14.3 Capacity, Production, Price, Cost, Gross and Revenue
7.14.4 Contact Information

7.15 Terumo Corporation Company
7.15.1 Company Profile
7.15.2 Product Picture and Specifications
7.15.2.1 Type I
7.15.2.2 Type II
7.15.2.3 Type III
7.15.3 Capacity, Production, Price, Cost, Gross and Revenue
7.15.4 Contact Information

7.16 Tepha, Inc. Company
7.16.1 Company Profile
7.16.2 Product Picture and Specifications
7.16.2.1 Type I
7.16.2.2 Type II
7.16.2.3 Type III
7.16.3 Capacity, Production, Price, Cost, Gross and Revenue
7.16.4 Contact Information

7.17 Svelte Medical Systems, Inc. Company
7.17.1 Company Profile
7.17.2 Product Picture and Specifications
7.17.2.1 Type I
7.17.2.2 Type II
7.17.2.3 Type III
7.17.3 Capacity, Production, Price, Cost, Gross and Revenue
7.17.4 Contact Information

7.18 Stentys, SA Company
7.18.1 Company Profile
7.18.2 Product Picture and Specifications
7.18.2.1 Type I
7.18.2.2 Type II
7.18.2.3 Type III
7.18.3 Capacity, Production, Price, Cost, Gross and Revenue
7.18.4 Contact Information

7.19 Sino Medical-Device Technology Co., Ltd. Company
7.19.1 Company Profile
7.19.2 Product Picture and Specifications
7.19.2.1 Type I
7.19.2.2 Type II
7.19.2.3 Type III
7.19.3 Capacity, Production, Price, Cost, Gross and Revenue
7.19.4 Contact Information

7.20 REVA Medical, Inc. Company
7.20.1 Company Profile
7.20.2 Product Picture and Specifications
7.20.2.1 Type I
7.20.2.2 Type II
7.20.2.3 Type III
7.20.3 Capacity, Production, Price, Cost, Gross and Revenue
7.20.4 Contact Information

7.21 OrbusNeich Company
7.21.1 Company Profile
7.21.2 Product Picture and Specifications
7.21.2.1 Type I
7.21.2.2 Type II
7.21.2.3 Type III
7.21.3 Capacity, Production, Price, Cost, Gross and Revenue
7.21.4 Contact Information

7.22 NanoCoeur, Inc. Company
7.22.1 Company Profile
7.22.2 Product Picture and Specifications
7.22.2.1 Type I
7.22.2.2 Type II
7.22.2.3 Type III
7.22.3 Capacity, Production, Price, Cost, Gross and Revenue
7.22.4 Contact Information

7.23 Minvasys Company
7.23.1 Company Profile
7.23.2 Product Picture and Specifications
7.23.2.1 Type I
7.23.2.2 Type II
7.23.2.3 Type III
7.23.3 Capacity, Production, Price, Cost, Gross and Revenue
7.23.4 Contact Information

7.24 Micell Technologies, Inc. Company
7.24.1 Company Profile
7.24.2 Product Picture and Specifications
7.24.2.1 Type I
7.24.2.2 Type II
7.24.2.3 Type III
7.24.3 Capacity, Production, Price, Cost, Gross and Revenue
7.24.4 Contact Information

7.25 Meril Life Sciences
7.25.1 Company Profile
7.25.2 Product Picture and Specifications
7.25.2.1 Type I
7.25.2.2 Type II
7.25.2.3 Type III
7.25.3 Capacity, Production, Price, Cost, Gross and Revenue
7.25.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Drug Eluting Stents (DES) Product Types
8.5 Market Share Analysis of Different Drug Eluting Stents (DES) Price Levels
8.6 Gross Margin Analysis of Different Drug Eluting Stents (DES) Applications

9 Marketing Trader or Distributor Analysis of Drug Eluting Stents (DES)
9.1 Marketing Channels Status of Drug Eluting Stents (DES)
9.2 Traders or Distributors of Drug Eluting Stents (DES) with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Drug Eluting Stents (DES)
9.4 United States Import, Export and Trade Analysis of Drug Eluting Stents (DES)

10 Development Trend of Drug Eluting Stents (DES) Industry 2016-2021
10.1 Capacity and Production Overview of Drug Eluting Stents (DES) 2016-2021
10.2 Production Market Share by Product Types of Drug Eluting Stents (DES) 2016-2021
10.3 Sales and Sales Revenue Overview of Drug Eluting Stents (DES) 2016-2021
10.4 United States Sales of Drug Eluting Stents (DES) by Applications 2016-2021
10.5 Import, Export and Consumption of Drug Eluting Stents (DES) 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Drug Eluting Stents (DES) 2016-2021

11 Industry Chain Suppliers of Drug Eluting Stents (DES) with Contact Information
11.1 Major Raw Materials Suppliers of Drug Eluting Stents (DES) with Contact Information
11.2 Manufacturing Equipment Suppliers of Drug Eluting Stents (DES) with Contact Information
11.3 Major Players of Drug Eluting Stents (DES) with Contact Information
11.4 Key Consumers of Drug Eluting Stents (DES) with Contact Information
11.5 Supply Chain Relationship Analysis of Drug Eluting Stents (DES)

12 New Project Investment Feasibility Analysis of Drug Eluting Stents (DES)
12.1 New Project SWOT Analysis of Drug Eluting Stents (DES)
12.2 New Project Investment Feasibility Analysis of Drug Eluting Stents (DES)

13 Conclusion of the United States Drug Eluting Stents (DES) Industry 2016 Market Research Report




List of Tables and Figures

Figure Picture of Drug Eluting Stents (DES)
Table Product Specifications of Drug Eluting Stents (DES)
Table Classification of Drug Eluting Stents (DES)
Figure United States Sales Market Share of Drug Eluting Stents (DES) by Product Types in 2015
Table Applications of Drug Eluting Stents (DES)
Figure United States Sales Market Share of Drug Eluting Stents (DES) by Applications in 2015
Figure Industry Chain Structure of Drug Eluting Stents (DES)
Table United States Industry Overview of Drug Eluting Stents (DES)
Table Industry Policy of Drug Eluting Stents (DES)
Table Industry News List of Drug Eluting Stents (DES)
Table Bill of Materials (BOM) of Drug Eluting Stents (DES)
Table Bill of Materials (BOM) Price of Drug Eluting Stents (DES)
Table Labor Cost of Drug Eluting Stents (DES)
Table Depreciation Cost of Drug Eluting Stents (DES)
Table Manufacturing Cost Structure Analysis of Drug Eluting Stents (DES) in 2015
Figure Manufacturing Process Analysis of Drug Eluting Stents (DES)
Table United States Price Analysis of Drug Eluting Stents (DES) 2011-2016 (USD/Unit)
Table United States Cost Analysis of Drug Eluting Stents (DES) 2011-2016 (USD/Unit)
Table United States Gross Analysis of Drug Eluting Stents (DES) 2011-2016
Table Capacity (K Units) and Commercial Production Date of United States Drug Eluting Stents (DES) Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Drug Eluting Stents (DES) Manufacturers in 2015
Table RandD Status and Technology Source of United States Drug Eluting Stents (DES) Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Drug Eluting Stents (DES) Key Manufacturers in 2015
Table United States Production of Drug Eluting Stents (DES) by Regions 2011-2016 (K Units)
Table United States Production Market Share of Drug Eluting Stents (DES) by Regions 2011-2016
Figure United States Production Market Share of Drug Eluting Stents (DES) by Regions in 2014
Figure United States Production Market Share of Drug Eluting Stents (DES) by Regions in 2015
Table United States Production of Drug Eluting Stents (DES) by Types in 2011-2016 (K Units)
Table United States Production Market Share of Drug Eluting Stents (DES) by Type in 2011-2016
Figure United States Production Market Share of Drug Eluting Stents (DES) by Type in 2014
Figure United States Production Market Share of Drug Eluting Stents (DES) by Type in 2015
Table United States Sales of Drug Eluting Stents (DES) by Applications 2011-2016 (K Units)
Table United States Production Market Share of Drug Eluting Stents (DES) by Applications 2011-2016
Figure United States Production Market Share of Drug Eluting Stents (DES) by Applications in 2014
Figure United States Production Market Share of Drug Eluting Stents (DES) by Applications in 2015
Table Price Comparison of United States Drug Eluting Stents (DES) Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Drug Eluting Stents (DES) 2011-2016
Table United States Consumption Volume of Drug Eluting Stents (DES) by Regions 2011-2016 (K Units)
Table United States Consumption Volume Market Share of Drug Eluting Stents (DES) by Regions 2011-2016
Figure United States Consumption Volume Market Share of Drug Eluting Stents (DES) by Regions in 2014
Figure United States Consumption Volume Market Share of Drug Eluting Stents (DES) by Regions in 2015
Table United States Consumption Value of Drug Eluting Stents (DES) by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Drug Eluting Stents (DES) by Regions 2011-2016
Figure United States Consumption Value Market Share of Drug Eluting Stents (DES) by Regions in 2014
Figure United States Consumption Value Market Share of Drug Eluting Stents (DES) by Regions in 2015
Table Consumption Price of Drug Eluting Stents (DES) by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Drug Eluting Stents (DES) 2011-2016 (K Units)
Table United States Capacity Market Share of Major Drug Eluting Stents (DES) Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Drug Eluting Stents (DES) 2011-2016 (K Units)
Table United States Production Market Share of Major Drug Eluting Stents (DES) Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Drug Eluting Stents (DES) 2011-2016 (K Units)
Table United States Sales Market Share of Major Drug Eluting Stents (DES) Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Drug Eluting Stents (DES) 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Drug Eluting Stents (DES) Manufacturers 2011-2016
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Drug Eluting Stents (DES) 2011-2016
Figure United States Capacity Utilization Rate of Drug Eluting Stents (DES) 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Drug Eluting Stents (DES) 2011-2016
Figure United States Production Market Share of Major Drug Eluting Stents (DES) Manufacturers in 2014
Figure United States Production Market Share of Major Drug Eluting Stents (DES) Manufacturers in 2015
Figure United States Sales Market Share of Major Drug Eluting Stents (DES) Manufacturers in 2014
Figure United States Sales Market Share of Major Drug Eluting Stents (DES) Manufacturers in 2015
Figure United States Sales (K Units) and Growth Rate of Drug Eluting Stents (DES) 2011-2016
Table United States Supply, Consumption and Gap of Drug Eluting Stents (DES) 2011-2016 (K Units)
Table United States Import, Export and Consumption of Drug Eluting Stents (DES) 2011-2016 (K Units)
Table Price of United States Drug Eluting Stents (DES) Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Drug Eluting Stents (DES) Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Drug Eluting Stents (DES) 2011-2016 (M USD)
Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Drug Eluting Stents (DES) 2011-2016
Table Abbott Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Abbott
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Abbott 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Abbott 2011-2016
Table Abbott Drug Eluting Stents (DES) SWOT Analysis
Table Medtronic Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Medtronic
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Medtronic 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Medtronic 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Medtronic 2011-2016
Table Medtronic Drug Eluting Stents (DES) SWOT Analysis
Table Terumo Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Terumo
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Terumo 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Terumo 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Terumo 2011-2016
Table Terumo Drug Eluting Stents (DES) SWOT Analysis
Table Biosensors International Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Biosensors International
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biosensors International 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Biosensors International 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Biosensors International 2011-2016
Table Biosensors International Drug Eluting Stents (DES) SWOT Analysis
Table AlviMedica Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of AlviMedica
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AlviMedica 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of AlviMedica 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of AlviMedica 2011-2016
Table AlviMedica Drug Eluting Stents (DES) SWOT Analysis
Table Zorion Medical Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Zorion Medical Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Zorion Medical Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Zorion Medical Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Zorion Medical Company 2011-2016
Table Zorion Medical Company Drug Eluting Stents (DES) SWOT Analysis
Table BioSurfaces Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of BioSurfaces
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of BioSurfaces 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of BioSurfaces 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of BioSurfaces 2011-2016
Table BioSurfaces Drug Eluting Stents (DES) SWOT Analysis
Table Biotronik Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Biotronik
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biotronik 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Biotronik 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Biotronik 2011-2016
Table Biotronik Drug Eluting Stents (DES) SWOT Analysis
Table Boston Scientific Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Boston Scientific
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Boston Scientific 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Boston Scientific 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Boston Scientific 2011-2016
Table Boston Scientific Drug Eluting Stents (DES) SWOT Analysis
Table ICON Medical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of ICON Medical
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ICON Medical 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of ICON Medical 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of ICON Medical 2011-2016
Table ICON Medical Drug Eluting Stents (DES) SWOT Analysis
Table Xenogenics Corporation Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Xenogenics Corporation Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Xenogenics Corporation Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Xenogenics Corporation Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Xenogenics Corporation Company 2011-2016
Table Xenogenics Corporation Company Drug Eluting Stents (DES) SWOT Analysis
Table VasoTech Inc. Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of VasoTech Inc. Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of VasoTech Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of VasoTech Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of VasoTech Inc. Company 2011-2016
Table VasoTech Inc. Company Drug Eluting Stents (DES) SWOT Analysis
Table University of Strathclyde Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of University of Strathclyde Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of University of Strathclyde Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of University of Strathclyde Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of University of Strathclyde Company 2011-2016
Table University of Strathclyde Company Drug Eluting Stents (DES) SWOT Analysis
Table Tryton Medical, Inc. Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Tryton Medical, Inc. Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Tryton Medical, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Tryton Medical, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Tryton Medical, Inc. Company 2011-2016
Table Tryton Medical, Inc. Company Drug Eluting Stents (DES) SWOT Analysis
Table Terumo Corporation Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Terumo Corporation Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Terumo Corporation Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Terumo Corporation Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Terumo Corporation Company 2011-2016
Table Terumo Corporation Company Drug Eluting Stents (DES) SWOT Analysis
Table Tepha, Inc. Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Tepha, Inc. Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Tepha, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Tepha, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Tepha, Inc. Company 2011-2016
Table Tepha, Inc. Company Drug Eluting Stents (DES) SWOT Analysis
Table Svelte Medical Systems, Inc. Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Svelte Medical Systems, Inc. Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Svelte Medical Systems, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Svelte Medical Systems, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Svelte Medical Systems, Inc. Company 2011-2016
Table Svelte Medical Systems, Inc. Company Drug Eluting Stents (DES) SWOT Analysis
Table Stentys, SA Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Stentys, SA Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Stentys, SA Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Stentys, SA Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Stentys, SA Company 2011-2016
Table Stentys, SA Company Drug Eluting Stents (DES) SWOT Analysis
Table Sino Medical-Device Technology Co., Ltd. Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of Sino Medical-Device Technology Co., Ltd. Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sino Medical-Device Technology Co., Ltd. Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of Sino Medical-Device Technology Co., Ltd. Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of Sino Medical-Device Technology Co., Ltd. Company 2011-2016
Table Sino Medical-Device Technology Co., Ltd. Company Drug Eluting Stents (DES) SWOT Analysis
Table REVA Medical, Inc. Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of REVA Medical, Inc. Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of REVA Medical, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of REVA Medical, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of REVA Medical, Inc. Company 2011-2016
Table REVA Medical, Inc. Company Drug Eluting Stents (DES) SWOT Analysis
Table OrbusNeich Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of OrbusNeich Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of OrbusNeich Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of OrbusNeich Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of OrbusNeich Company 2011-2016
Table OrbusNeich Company Drug Eluting Stents (DES) SWOT Analysis
Table NanoCoeur, Inc. Company Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drug Eluting Stents (DES) Picture and Specifications of NanoCoeur, Inc. Company
Table Drug Eluting Stents (DES) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of NanoCoeur, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Capacity (K Units), Production (K Units) and Growth Rate of NanoCoeur, Inc. Company 2011-2016
Figure Drug Eluting Stents (DES) Production (K Units) and United States Market Share of NanoCoeur, Inc. Company 2011-2016
Table NanoCoeur, Inc. Company Drug Eluting Stents (DES) SWOT Analysis
Tab

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Drug Eluting Stent Market, By Polymer-based Coatings, Polymer-free Coatings, By Application, And Segment Forecasts To 2024

Drug Eluting Stent Market, By Polymer-based Coatings, Polymer-free Coatings, By Application, And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global drug eluting stent market is anticipated to reach USD 9.2 billion by 2024, according to a new report by Grand View Research, Inc. The increasing geriatric population and the high prevalence ...

Bioabsorbable Stents - Global Market Outlook (2016-2022)

Bioabsorbable Stents - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Bioabsorbable Stents Market is accounted for $0.35 billion in 2015 and is expected to reach $3.56 billion by 2022 growing at a CAGR of 39.2% during the forecast ...

Drug Eluting Stents Market Analysis & Trends- Product (Polymer-based Coatings, Non biodegradable Polymers, Nanoporous Surface and Polymer free Coatings)and Drugs Used (Anti-neoplastics, Immunosupressives and Enhanced Healing Factors) - Forecast to 2025

Drug Eluting Stents Market Analysis & Trends- Product (Polymer-based Coatings, Non biodegradable Polymers, Nanoporous Surface and Polymer free Coatings)and Drugs Used (Anti-neoplastics, Immunosupressives and Enhanced Healing Factors) - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Drug Eluting Stents Market is poised to grow at a CAGR of around 3.8% over the next decade to reach approximately $9.45 billion by 2025. Some of the prominent trends that the market is Recent ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.